tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Neurizon Therapeutics’ NUZ-001 Shows Promising Blood-Brain Barrier Penetration
Company AnnouncementsNeurizon Therapeutics’ NUZ-001 Shows Promising Blood-Brain Barrier Penetration
2d ago
Neurizon Therapeutics to Release Shares from Escrow
PremiumCompany Announcements
Neurizon Therapeutics to Release Shares from Escrow
6d ago
Neurizon Therapeutics Relocates Headquarters to Enhance Operations
PremiumCompany Announcements
Neurizon Therapeutics Relocates Headquarters to Enhance Operations
20d ago
Neurizon Therapeutics to Present Promising ALS Treatment Findings at Global Summit
PremiumCompany Announcements
Neurizon Therapeutics to Present Promising ALS Treatment Findings at Global Summit
1M ago
Neurizon Therapeutics to Present Q3 FY2025 Results and Progress on ALS Treatment
PremiumCompany Announcements
Neurizon Therapeutics to Present Q3 FY2025 Results and Progress on ALS Treatment
2M ago
Neurizon Therapeutics Reports Promising Results from NUZ-001 ALS Study
PremiumCompany AnnouncementsNeurizon Therapeutics Reports Promising Results from NUZ-001 ALS Study
2M ago
Neurizon Therapeutics Advances ALS Drug Development with Key Milestones
Premium
Company Announcements
Neurizon Therapeutics Advances ALS Drug Development with Key Milestones
2M ago
Neurizon Therapeutics Announces Quarterly Shareholder Update Webinar
Premium
Company Announcements
Neurizon Therapeutics Announces Quarterly Shareholder Update Webinar
2M ago
Neurizon Therapeutics Strengthens Leadership with New CFO Appointment
PremiumCompany Announcements
Neurizon Therapeutics Strengthens Leadership with New CFO Appointment
2M ago
Neurizon Therapeutics Bolsters Leadership Team with Strategic Appointments
PremiumCompany Announcements
Neurizon Therapeutics Bolsters Leadership Team with Strategic Appointments
2M ago
Neurizon Therapeutics Reports Promising Study Results on NUZ-001
PremiumCompany Announcements
Neurizon Therapeutics Reports Promising Study Results on NUZ-001
3M ago
Neurizon’s NUZ-001 Shows Promise in Neurodegenerative Disease Treatment
PremiumCompany Announcements
Neurizon’s NUZ-001 Shows Promise in Neurodegenerative Disease Treatment
3M ago
Neurizon Therapeutics Advances ALS Treatment with Promising Trial Updates
PremiumCompany AnnouncementsNeurizon Therapeutics Advances ALS Treatment with Promising Trial Updates
3M ago
Neurizon Therapeutics Takes Proactive Steps to Lift FDA Hold on ALS Drug
Premium
Company Announcements
Neurizon Therapeutics Takes Proactive Steps to Lift FDA Hold on ALS Drug
3M ago
Neurizon Therapeutics Reports Significant Loss Amidst Strategic Shift
Premium
Company Announcements
Neurizon Therapeutics Reports Significant Loss Amidst Strategic Shift
4M ago
Neurizon Therapeutics to Present Half-Year Results and FDA Feedback on ALS Treatment
PremiumCompany Announcements
Neurizon Therapeutics to Present Half-Year Results and FDA Feedback on ALS Treatment
4M ago
Neurizon Receives FDA Guidance on NUZ-001 IND Application
PremiumCompany Announcements
Neurizon Receives FDA Guidance on NUZ-001 IND Application
4M ago
Neurizon Therapeutics Announces Half-Year Update Webinar
PremiumCompany Announcements
Neurizon Therapeutics Announces Half-Year Update Webinar
4M ago
Director’s Interest Update at Neurizon Therapeutics
PremiumCompany Announcements
Director’s Interest Update at Neurizon Therapeutics
5M ago
Neurizon Secures US Patent for NUZ-001, Strengthening Market Position
PremiumCompany AnnouncementsNeurizon Secures US Patent for NUZ-001, Strengthening Market Position
5M ago
Neurizon Therapeutics Issues Unlisted Options in Employee Incentive Scheme
Premium
Company Announcements
Neurizon Therapeutics Issues Unlisted Options in Employee Incentive Scheme
5M ago
Neurizon Therapeutics Advances ALS Treatment with Promising Results and Regulatory Milestones
Premium
Company Announcements
Neurizon Therapeutics Advances ALS Treatment with Promising Results and Regulatory Milestones
5M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >